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ABSTRACT 
Central accumulation and distribution of body fat (BF) is an important cardiometabolic risk 
factor. Waist-to-hip ratio (WHR), commonly elevated in non-alcoholic fatty liver disease (NAFLD) 
patients, has been endorsed as a risk related marker of central BF content and distribution, but no 
standardized waist circumference measurement protocol (WCmp) has been proposed. We aimed to 
investigate whether using different WCmp affects the strength of association between WHR and BF 
content and distribution in NAFLD patients. BF was assessed with Dual Energy X-ray Absorptiometry 
(DXA) in 28 NAFLD patients (19 males, 51 ± 13 yrs, and 9 females, 47 ± 13 yrs). Waist circumference 
(WC) was measured using four different WCmp (WC1: minimal waist; WC2: iliac crest; WC3: mid-
distance between iliac crest and lowest rib; WC4: at the umbilicus) and WHR was calculated 
accordingly (WHR1, WHR2, WHR3 and WHR4, respectively). High WHR was found in up to 84.6% of 
subjects, depending on the WHR considered. With the exception of WHR1, all WHR correlated well 
with abdominal BF (r=0.47 for WHR1; r=0.59 for WHR2 and WHR3; r=0.58 for WHR4) and BF 
distribution (r=0.45 for WHR1; r=0.56 for WHR2 and WHR3; r=0.51 for WHR4), controlling for age, 
sex and body mass index (BMI). WHR2 and WHR3 diagnosed exactly the same prevalence of high 
WHR (76.9%). The present study confirms the strong relation between WHR and central BF, 
regardless of WCmp used, in NAFLD patients. WHR2 and WHR3 seemed preferable for use in clinical 
practice, interchangeably, for the diagnosis of high WHR in NAFLD patients. 
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Waist-to-hip ratio (WHR) has been shown to be closely related to the occurrence of 
non-alcoholic fatty liver disease (NAFLD) (Zheng et al., 2012), a metabolic condition that may 
lead to advanced fibrosis, cirrhosis, liver failure and death (Angulo, 2002). WHR has also 
been found to be associated with increased risk of cardiovascular events (Gruson et al., 
2010), which is also increased in NAFLD patients (Targher et al., 2005). Besides being a 
known cardiovascular risk factor (Ritchie et al., 2007), excess whole and in particular central 
body fat (BF) accumulation, highly common in NAFLD patients (Browning et al., 2004), have 
also been found to increase the risk of NAFLD (Park et al., 2007). It is therefore important to 
establish standardized clinical body composition surrogates, and potential therapy targets, 
particularly in higher risk sub-populations such as patients with NAFLD.  
WHR is assumed to reflect the distribution of fat throughout the body meaning that a 
high WHR should represent a preferential abdominal or central accumulation of BF (Egger, 
1992), and it has largely proven to be so (Chan et al., 2003; Savgan-Gurol et al., 2010; Taylor 
et al., 1998) yet conflicting results have also been found (Ketel et al., 2007). The considerable 
variation in methodology and results found in the literature may be limiting a standardized 
and wider usage of this body index.  The importance of a single standardized measurement 
protocol to calculate WHR has been identified (Croft et al., 1995; Houmard et al., 1991), but 
none has been universally recognized or endorsed, and therefore a wide diversity of 
methods can be found in the literature (Lear et al., 2009). The use of WHR is described in the 
literature since the early 1980’s using WC measured at the umbilicus (Larsson et al., 1984), 
at the minimal waist (Evans et al., 1984) or at the mid distance between the lower rib and 
the iliac crest (Lapidus et al., 1984). In the early 1990’s WHR was proposed to be calculated 
using measurements of waist circumference (WC) at the minimal waist (Nesheim, 1990), 
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however WC measured at the mid distance between lowest rib and iliac crest has been the 
most used protocol (Lear et al., 2009). 
To our knowledge it is unknown whether the use of different commonly used waist 
circumferences, with different measuring sites, affect the relation between WHR and both 
whole and central BF content and BF distribution. Therefore the aim of the present study 
was to find if any of the most used WC measurement protocol (WCmp) is better to calculate 
WHR for use in clinical practice with NAFLD patients as a surrogate of whole and central BF 
content and BF distribution.  
 
METHODS    
Subjects:  
This study was conducted at Exercise and Health Laboratory, from the 
Interdisciplinary Centre for the Study of Human Performance (Faculty of Human Kinetics, 
Technical University of Lisbon, Portugal). To be selected for the present study subjects had 
to be over 18 years of age without history of hepatotoxic substance intake (eg. steroids) and 
tobacco consumption. Exclusion criteria included alcohol consumption over 20 g/day; the 
presence of other potential causes for fatty liver disease, including viral hepatitis, auto-
immune disease and others; any physical and/or mental disabilities or any condition that 
constituted an absolute restriction to exercise, or other diagnosed diseases, except for 
metabolic and cardiovascular diseases (insulin resistance, hypertension or dyslipidemia), 
with mandatory specific pharmacologic therapy. We studied 28 NAFLD patients (19 males 
and 9 females; 25 – 68 yrs) who were diagnosed through liver biopsy (n=13) or ultrasound 
(n=15). Subjects were recruited from the outpatient medical departments in Santa Maria 
Hospital and Curry Cabral Hospital; 59 consecutive patients were invited to participate based 
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on inclusion criteria; 28 of the 37 individuals who accepted the invitation were included in 
the study after exclusion criteria were considered. All subjects gave their written informed 
consent before taking part in the study. All methods used in the present study complied with 
ethics and Portuguese laws and were approved by Faculty of Human Kinetics institutional 
review board for human studies.    
Body composition:  
Body composition (BC) was assessed using Dual Energy X-ray Absorptiometry (DXA) 
(Explorer W, Hologic; Waltham, MA, USA; Fan beam mode) whole body scans and 
anthropometric measurements. Repeated measurements of whole body DXA scans were 
performed at our lab in 18 young adults, for precision assessment purposes (Lohman et al., 
2005), and showed a coefficient of variation (CV) of 1.7% for total BF mass and 1.5% for total 
%BF. All scans were performed in the morning after an overnight 12 h fast. Quality control 
with spine phantom was conducted every morning, and with step phantom every week. By 
default, DXA software (QDR for windows, version 12.4) estimates the head, trunk, arms and 
legs, both left and right, regional fat content, according to a three-compartment model (fat 
mass, lean tissue and bone mass). The analyzed trunk region of interest (ROI) (CV = 0.5%) 
includes the chest, abdomen and pelvis regions from the scan (figure 1). All scans analyses 
were made by the same observer. All scans were submitted to additional analysis by ROI to 
assess fat content of the abdominal (R1) and central abdominal (R2) regions (figure 1) (CV = 
1.0 %). The upper and lower limits of R1 and R2 were determined as the upper edge of the 
second lumbar vertebra to the lower edge of the fourth lumbar vertebra, respectively 
(Kamel et al., 2000; Park et al., 2002; Pimenta et al., 2014). Lateral limits of R1 were the 
vertical continuation of the lateral sides of the rib cage, as to exclude the lateral 
subcutaneous fat of the trunk, including however the anterior and posterior subcutaneous 
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abdominal fat, as well as the intra-abdominal fat (Kamel et al., 2000; Pimenta et al., 2014) , 
whereas the lateral limits of R2 were determined as to include all trunk width, but exclude 
any upper limb scan area (Park et al., 2002; Pimenta et al., 2014) (figure 1). Absolute and 
relative BF content results were reported to the nearest 0.01kg and 0.1%, respectively. 
Anthropometric measurements consisted of weight, height and body mass index 
(BMI) as well as WC and WHR. Standardization procedures were taken into account to 
minimize error (Agarwal et al., 2009; World Health Organization, 2011). All WC 
measurements were made with subjects in a standing comfortable position facing the 
observer, with the arms crossed over their chest, in their underwear, in a 12h fasting state. 
All measurements were made by the same technician, who was a trained level 2 technician, 
certified by the International Society for the Advancement of Kinanthropometry. Body 
weight was measured to the nearest 0.1kg, and height was measured to the nearest 0.1 cm, 
on a scale with an attached stadiometer (model 770, Seca; Hamburg, Deutschland), 
according to standard protocol (Lohman, Roche, & Martorell, 1988). Subjects’ BMI was 
calculated by dividing the weight, in kg, by the squared height, in meters (BMI = weight [kg] / 
height [m]2). WC was measured using an inelastic flexible metallic tape (Lufkin - W606PM, 
Vancouver, Canada) parallel to the floor after a tidal expiration, to the nearest 0.1cm, at the 
following sites: the narrowest torso (WC1) (Lohman et al., 1988), also called minimal waist 
(Ross et al., 2008); the superior border of the iliac crest (WC2) (McGuire et al., 2010; 
National Institutes of Health, 1994); the midpoint between the lowest rib and iliac crest 
(WC3) (WHO, 2011) and the umbilicus (WC4) (Ketel et al., 2007; Savgan-Gurol et al., 2010). 
Hip circumference (Hip-C) was measured horizontally at the level of the widest portion of 
the buttocks (Lohman et al., 1988; Nesheim, 1990; WHO, 2011). WHR was calculated by 
dividing each subject’s WC by the Hip-C, both in centimeters (WHR = WC [cm] / Hip-C [cm]). 
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Four different WHR were calculated for each subject: WHR1, WHR2, WHR3 and WHR4, 
calculated using WC1, WC2, WC3 and WC4, respectively. The cut off values of 0.95 for men 
and 0.80 for women were considered for the identification of high WHR (Nesheim, 1990). All 
anthropometric measurements were repeated two times. A third measurement was taken 
whenever the second measurement differed more than 1cm (for waist and height 
measurements) or 0.5kg (for weight measurement) from the first measurement. The results 
obtained in the second measurement were reported whenever no third measurement was 
taken. When a third measurement was taken we reported the mode of all three 
measurements or, if mode was absent, the median was reported. By using this procedure we 
sought to always use the most suitable value that was actually measured on the subjects 
(instead of mean values) (Pimenta et al., 2015).  
Statistical methods:  
Descriptive statistics are presented as mean ± SD and range for all analyzed variables. 
The Gaussian distribution of the data was assessed with the Shapiro-Wilk goodness-of-fit 
test. Paired samples t-test was used to compare different WHR. The association of all WHR 
with the DXA measures was assessed using partial and semipartial (Cohen et al., 1983) 
correlations, controlling for age, sex and BMI. A statistical power of 80% (β = 0.20) at a 
significance level of 5% (α = 0.05) was considered statistically significant. Consequently only 
coefficients of correlation equal or superior to 0.5, corresponding to a large effect size, 
attained this criteria (p≤0.05 and β≤0.20) and could be considered significant (this is in 
accordance with Cohen et al. (1983) to assure that results are unexposed to type I and II 
errors, despite a rather modest sample size). Pairs of correlation coefficients obtained 
between each WHR with each dependent variable were compared, using Z statistic, to find if 
any WHR was more closely associated with BF content and distribution. Statistical 
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calculations were performed using the IBM SPSS Statistics version 19 (SPSS, inc, Chicago, IL), 
except for Z statistic which was performed using Medcalc version 11.1.1.0 (MedCalc 
Software, Mariakerke, Belgium). 
 
RESULTS 
Mean values for all variables are presented in table 1. High WHR was present in 69 to 
85%, according to the WHR used, yet WHR2 and WHR3 diagnosed exactly the same 
prevalence of high WHR in the studied sample. Results for WHR were different when using 
different WC (WHR4>WHR2>WHR3>WHR1). Mean age of the studied sample was 51±13 yrs 
for men and 47±13 yrs for women, with no differences between sexes (p=0.519 on 
independent samples t test). Subjects were taking one or more of the following medications: 
platelet inhibitors, angiotensin-converting enzyme inhibitors, nitrates, statins, ezitimibe, 
nicotinic acid and biguanides, with similar use among sexes 
The results for partial and semipartial correlations, controlled for sex and age (table 
2), showed WHR1 was the only WHR not correlated with any BF depot. All other WHR were 
positively associated with both Abdominal BF and Central Abdominal BF. Regarding BF 
distribution markers, WHR1 was the only WHR not correlated with Trunk BF-to-Appendicular 
BF ratio, but all WHR correlated positively with Abdominal BF-to-Total BF ratio. The results 
for partial and semipartial correlations, controlled for sex, age and BMI (table 3), showed 
that all but WHR1 were positively correlated with abdominal region BF depots and both 
Trunk BF-to-Appendicular BF ratio and Abdominal BF-to-Total BF ratio.  
All coefficients of correlation between WHR and BF content variables remained 
stable either when using partial correlations (when WHR and DXA measures variation 
associated with control variables was removed from the correlations) or when using 
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semipartial correlations (when only WHR variation associated with control variables was 
removed from the correlations). Associations were absent for all WHR with all BF 
distribution markers, when semipartial correlations were used. The differences between 
coefficients of correlation obtained with and without BMI as a control variable were not 
significant (p>0.05 in all coefficient of correlation comparisons by Z statistics, using Medcalc 
version 11.1.1.0 [MedCalc Software, Mariakerke, Belgium], data not shown). Yet WHR1 was 
found not to be correlated with any BF content or distribution variable when BMI was added 
as controlling variable (p>0.05). No differences were found in the comparison between pairs 
of coefficients of correlation (listed in table 2 and 3) obtained between competing WHR with 
each dependent variable, using Z statistics (p>0.05 in all comparisons, data not shown). 
DISCUSSION  
Mean WHR was rather high, and the prevalence of elevated WHR was high in the 
present sample when compared to the general population (69 to 85% found in the present 
study, depending on the WCmp used to calculate WHR, vs 42 to 58%, reported elsewhere) 
(Akpinar et al., 2007). This was expected as NAFLD patients have been shown to have higher 
WHR (Zheng et al., 2012). The differences observed in the WHR mean values, calculated 
using different WC, suggest WHR calculated using different WCmp are not interchangeable. 
This has important implications in clinical practice, advising a consistent choice of the WCmp 
used for the calculation of WHR. But the literature is neither consistent nor consensual 
regarding which WCmp should be used for the calculation of WHR. Several previous studies 
have reported WC magnitudes to be influenced by WCmp (Mason  et al., 2009; Wang et al., 
2003). Even though the present study shows differences between all WHR, both WHR2 and 
WHR3 diagnosed exactly the same prevalence of high WHR, using proposed cut-off values 
(Nesheim, 1990), suggesting they could be used interchangeably for the diagnosis of high 
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WHR in the present sample, as has been proposed for the general population (Ross et al., 
2008). WC measured at the umbilicus is commonly used, including in NAFLD patients (Rector 
et al., 2011; Targher et al., 2008), and has been found useful for the prediction of whole and 
central BF as well as BF distribution in these patients (Pimenta et al., 2015). However, the 
use of bony landmarks had been recommended to increase precision (Klein et al., 2007) and 
reliability (McGuire et al., 2010; Ross et al., 2008) making WC4 and, consequently, WHR4 less 
appealing. 
WHR were only found to be associated with central BF depots. When controlled for 
age, sex and BMI, WHR1 showed no correlations with all DXA measures and ratios. WHR1 
was positively correlated with abdominal BF-to-Total BF ratio, but only when BMI was not 
included as a controlling variable. The inconsistency of WHR1 correlations suggests that this 
is more prone to be influenced by general adiposity than all other studied WHR. WHR has 
been proposed to be calculated using WC measured at minimum waist (Nesheim, 1990) 
however this seemed to have the least consistent and predictable relation with BF, in the 
present study. Though not consensual, the association between WHR and central BF has 
been previously reported (Chan et al., 2003; Savgan-Gurol et al., 2010) but not until now in 
NAFLD patients. WHR, using WC measured at mid-distance between lowest rib and iliac 
crest, was previously shown to be positively correlated with abdominal adipose tissue 
compartments, as assessed by magnetic resonance imaging (MRI) in free-living men (Chan et 
al., 2003). Coefficients of correlation over 0.70 were also found between WHR, using WC 
measured at the umbilicus, and both visceral and subcutaneous adipose tissue, as assessed 
by MRI at L4 (Savgan-Gurol et al., 2010). Even though these results are in accordance to the 
findings of the present study, to our knowledge no other studies focused on such 
relationships in non-alcoholic fatty liver disease patients. The considerable differences in 
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methodology, including considerable differences in the studied populations, prevent 
extended interpretations. Opposing results were also found when correlating WHR, using 
WC measured at the umbilicus, with DXA assessed BF depots similar to the present study, 
including central BF (r<0.28) and peripheral BF (r<0.16) (Ketel et al., 2007). Though these 
differences may be explained by sample differences, including different health status.  
In the present sample of NAFLD patients WHR2, WHR3 and WHR4 were significantly 
associated with body fat distribution either when controlling only for age and sex (table 2), 
or when adding BMI as controlling variable (table 3). The present results do not support such 
previously reported high coefficients of correlation found between WHR using minimal 
waist, and both DXA derived trunk-to-leg BF ratio (r=0.62) and waist-to-hip BF ratio (r=0.78) 
(Taylor et al., 1998). However, these results were observed on a sample of healthy white 
women, which is profusely different from the sample considered in the present study. Unlike 
the present results, a small coefficient of correlation (r<0.3) was reported between WHR, 
using WC measured at the umbilicus, and a similar variable to the trunk BF-to-appendicular 
BF ratio, used in the present study (Ketel et al., 2007). Yet this was found on a sample of 
adolescent girls. The coefficients of correlation obtained between the different WHR and all 
studied BF depots and BF distribution variables were not significantly different (p>0.05) 
when comparing results obtained with the all WHR for each dependent variable using Z 
statistics (data not shown). Both central BF accumulation (Ritchie et al., 2007) and high WHR 
(Gruson et al., 2010) have been reported to be positively associated with increased risk of 
cardiovascular diseases. Considering both the high prevalence of elevated WHR and the 
strong association between WHR and both central body fat content and distribution 
(particularly WHR 2 and WHR3, which seem more consistent) found in the present sample, it 
is reasonable to assume that this may suggest a higher cardiometabolic risk in the studied 
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patients. This assumption is concordant with the higher risk of cardiovascular events 
previously reported in NAFLD patients (Targher et al., 2005). 
There are several strengths and limitations to this study. The studied WCmp do not 
cover all protocols existent in the literature, however the focus was set on the most 
commonly used and endorsed by prominent institutions for use in clinical setting (Klein et 
al., 2007; McGuire & Ross, 2010; Ross et al., 2008). Also the used BC assessment method 
(DXA), a gold standard instrument to assess BC in a three compartment model, is unable to 
determine visceral adiposity independently from subcutaneous fat. However there is a 
strong correlation between abdominal fat estimated from selected DXA ROI and visceral fat 
assessed by MRI (Park et al., 2002) and computed tomography  (Snijder et al., 2002). Finally, 
because a cross-sectional approach was used, there could not be established the usefulness 
of the studied WHR to assess changes in BF depots content neither in BF distribution, based 
on the present results.  
The present study confirms the strong association between WHR and central BF, 
even after removing the effect of age, sex and BMI, in NAFLD patients. However WHR using 
WC measured at minimal waist seems to be less consistent as a BF content or distribution 
surrogate in NAFLD. Thus, present results may endorse an interchangeable use of WHR2 
(measured at the superior border of the iliac crest) and WHR3 (measured at the mid-
distance between the lowest rib and the iliac crest) for identifying subjects with high WHR 
and therefore at higher cardiometabolic risk. Based on present results both WHR2 and 
WHR3 seem preferable to use in NAFLD patients. Additional research is needed to confirm 
the influence of different WCmp in the relation of WHR with other NAFLD and 
cardiometabolic risk factors.  
 
13 
 
 
  
ACKNOWLEDGEMENTS 
The study was designed by NP and HSC; data were collected and analyzed by NP, XM, 
HCP and JSN; data interpretation and manuscript preparation were undertaken by NP, HSC, 
XM, HCP, and LS. All authors approved the final version of the paper” 
The first author of this paper is supported by a research grant from the Foundation 
for Science and Technology (FCT), Ministry of Education and Science of Portugal (grant: 
SFRH/ BD/ 70515/ 2010). 
The present study was funded by: the Centre for the Study of Human Performance, 
Portuguese Foundation for Science and Technology, Lisbon, Portugal; co-financed by 
national funds through the Programa Operacional do Alentejo (ALENT-07-0262-FEDER-
001883) - Parque de Ciência e Tecnologia do Alentejo - Laboratório de Investigação em 
Desporto e Saúde, Sport Sciences School of Rio Maior (ESDRM) – Politechnic Institute of 
Santarém (IPS), Portugal. 
The authors declare no conflict of interest.  
  
14 
 
 
  
REFERENCES 
Agarwal, S. K., Misra, A., Aggarwal, P., Bardia, A., Goel, R., Vikram, N. K., … Pandey, R. 
M. (2009). Waist circumference measurement by site, posture, respiratory phase, and 
meal time: implications for methodology. Obesity (Silver Spring), 17(5), 1056–61. 
http://doi.org/10.1038/oby.2008.635 
Akpinar, E., Bashan, I., Bozdemir, N., & Saatci, E. (2007). Which is the best anthropometric 
technique to identify obesity: body mass index, waist circumference or waist-hip 
ratio? Collegium Antropologicum, 31(2), 387–93. 
Angulo, P. (2002). Nonalcoholic fatty liver disease. New England Journal of Medicine, 
346(16), 1221–1231. 
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., 
… Hobbs, H. H. (2004). Prevalence of hepatic steatosis in an urban population in the 
United States: impact of ethnicity. Hepatology, 40(6), 1387–95. 
Chan, D. C., Watts, G. F., Barrett, P. H., & Burke, V. (2003). Waist circumference, waist-to-
hip ratio and body mass index as predictors of adipose tissue compartments in men. 
Quarterly Journal of Medicine, 96(6), 441–7. 
Cohen, J., & Cohen, P. (1983). Applied Multiple Regression/Correlation Analysis for the 
Behavioral Sciences (2nd ed.). Hillsdale, NJ: Lawrence Erkbaum Associates, Inc. 
Croft, J. B., Keenan, N. L., Sheridan, D. P., Wheeler, F. C., & Speers, M. A. (1995). Waist-to-
hip ratio in a biracial population: measurement, implications, and cautions for using 
guidelines to define high risk for cardiovascular disease. Journal of the American 
Dietetic Association, 95(1), 60–4. http://doi.org/10.1016/S0002-8223(95)00014-3 
Egger, G. (1992). The case for using waist to hip ratio measurements in routine medical 
checks. Medical Journal of Australia, 156(4), 280–5. 
15 
 
 
  
Evans, D. J., Hoffmann, R. G., Kalkhoff, R. K., & Kissebah, A. H. (1984). Relationship of 
body fat topography to insulin sensitivity and metabolic profiles in premenopausal 
women. Metabolism: Clinical and Experimental, 33(1), 68–75. 
Gruson, E., Montaye, M., Kee, F., Wagner, A., Bingham, A., Ruidavets, J. B., … 
Dallongeville, J. (2010). Anthropometric assessment of abdominal obesity and 
coronary heart disease risk in men: the PRIME study. Heart, 96(2), 136–40. 
http://doi.org/10.1136/hrt.2009.171447 
Houmard, J. A., Wheeler, W. S., McCammon, M. R., Wells, J. M., Truitt, N., Hamad, S. F., 
… Barakat, H. A. (1991). An evaluation of waist to hip ratio measurement methods in 
relation to lipid and carbohydrate metabolism in men. Internation Journal of Obesity, 
15(3), 181–8. 
Kamel, E. G., McNeill, G., & Van Wijk, M. C. (2000). Usefulness of anthropometry and 
DXA in predicting intra-abdominal fat in obese men and women. Obesity Research, 
8(1), 36–42. 
Ketel, I. J., Volman, M. N., Seidell, J. C., Stehouwer, C. D., Twisk, J. W., & Lambalk, C. B. 
(2007). Superiority of skinfold measurements and waist over waist-to-hip ratio for 
determination of body fat distribution in a population-based cohort of Caucasian 
Dutch adults. European Journal of Endocrinology, 156(6), 655–61. 
http://doi.org/10.1530/EJE-06-0730 
Klein, S., Allison, D. B., Heymsfield, S. B., Kelley, D. E., Leibel, R. L., Nonas, C., & Kahn, 
R. (2007). Waist circumference and cardiometabolic risk: a consensus statement from 
Shaping America’s Health: Association for Weight Management and Obesity 
Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and 
the American Diabetes Association. The American Journal of Clinical Nutrition, 
85(5), 1197–1202. 
16 
 
 
  
Lapidus, L., Bengtsson, C., Larsson, B., Pennert, K., Rybo, E., & Sjöström, L. (1984). 
Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year 
follow up of participants in the population study of women in Gothenburg, Sweden. 
British Medical Journal (Clinical Research Ed.), 289(6454), 1257–1261. 
Larsson, B., Svardsudd, K., Welin, L., Wilhelmsen, L., Bjorntorp, P., & Tibblin, G. (1984). 
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and 
death: 13 year follow up of participants in the study of men born in 1913. British 
Medical Journal (Clinical Research Ed.), 288(6428), 1401–4. 
Lear, S. A., James, P. T., Ko, G. T., & Kumanyika, S. (2009). Appropriateness of waist 
circumference and waist-to-hip ratio cutoffs for different ethnic groups. European 
Journal of Clinical Nutrition, 64(1), 42–61. http://doi.org/10.1038/ejcn.2009.70 
Lohman, T. G., & Chen, Z. (2005). Dual-Energy X-Ray Absorptiometry. In S. B. Heymsfield, 
T. G. Lohman,  z. Wang, & S. Going (Eds.), Human Body Composition (pp. 63–78). 
Champaign: Human Kinetics. 
Lohman, T. G., Roche, A. F., & Martorell, R. (1988). Anthropometric Standardization 
Reference Manual. Champaign: Human Kinetics. 
Mason, C., & Katzmarzyk, P. T. (2009). Variability in waist circumference measurements 
according to anatomic measurement site. Obesity (Silver Spring), 17(9), 1789–95. 
http://doi.org/10.1038/oby.2009.87 
McGuire, K. A., & Ross, R. (2010). Revised Protocol for Measurement of Waist 
Circumference. In CSEP (Ed.), Canadian physical activity, fitness and lifestyle 
approach (3rd ed., pp. 13–14). Ottawa, Ont.: Canadian Society for Exercise 
Physiology. 
17 
 
 
  
National Institute of Health. (1994). Plan and operation of the Third National Health and 
Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. 
Vital Health Stat, 1(32), 1–407. 
Nesheim, M. C. (1990). Report of the Dietary Guidelines Advisory Committee on the Dietary 
Guidelines for Americans 1990. (U. D. of Agriculture, Trans.). Hyattsville, Maryland: 
US Department of Agriculture and US Department of Health and Human Services. 
Park, S. H., Kim, B. I., Kim, S. H., Kim, H. J., Park, D. I., Cho, Y. K., … Jeon, W. K. (2007). 
Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver 
disease among overweight men. Journal of the American College of Nutrition, 26(4), 
321–6. 
Park, Y. W., Heymsfield, S. B., & Gallagher, D. (2002). Are dual-energy X-ray 
absorptiometry regional estimates associated with visceral adipose tissue mass? 
International Journal of Obesity and Related Metabolic Disorders, 26(7), 978–83. 
Pimenta, N. M., Santa-Clara, H., Cortez-Pinto, H., Silva-Nunes, J., da Lapa Rosado, M., 
Sousa, P. J., … Fernhall, B. (2014). Body composition and body fat distribution are 
related to cardiac autonomic control in non-alcoholic fatty liver disease patients. 
European Journal of Clinical Nutrition, 68(2), 241–246. 
http://doi.org/10.1038/ejcn.2013.249 
Pimenta, N. M., Santa-Clara, H., Melo, X., Cortez-Pinto, H., Silva-Nunes, J., & Sardinha, L. 
B. (2015). Finding the Best Waist Circumference Measurement Protocol in Patients 
With Nonalcoholic Fatty Liver Disease. Nutrition in Clinical Practice, 
0884533615583092. 
Rector, R. S., & Thyfault, J. P. (2011). Does physical inactivity cause nonalcoholic fatty liver 
disease? Journal of Applied Physiology, 111(6), 1828–1835. 
http://doi.org/10.1152/japplphysiol.00384.2011 
18 
 
 
  
Ritchie, S. A., & Connell, J. M. C. (2007). The link between abdominal obesity, metabolic 
syndrome and cardiovascular disease. Nutrition, Metabolism and Cardiovascular 
Diseases, 17(4), 319–326. http://doi.org/10.1016/j.numecd.2006.07.005 
Ross, R., Berentzen, T., Bradshaw, A. J., Janssen, I., Kahn, H. S., Katzmarzyk, P. T., … 
Després, J.-P. (2008). Does the relationship between waist circumference, morbidity 
and mortality depend on measurement protocol for waist circumference? Obesity 
Reviews, 9(4), 312–325. http://doi.org/10.1111/j.1467-789X.2007.00411.x 
Savgan-Gurol, E., Bredella, M., Russell, M., Mendes, N., Klibanski, A., & Misra, M. (2010). 
Waist to hip ratio and trunk to extremity fat (DXA) are better surrogates for IMCL and 
for visceral fat respectively than for subcutaneous fat in adolescent girls. Nutrition & 
Metabolism, 7, 86. http://doi.org/10.1186/1743-7075-7-86 
Snijder, M. B., Visser, M., Dekker, J. M., Seidell, J. C., Fuerst, T., Tylavsky, F., … Harris, T. 
B. (2002). The prediction of visceral fat by dual-energy X-ray absorptiometry in the 
elderly: a comparison with computed tomography and anthropometry. International 
Journal of Obesity and Related Metabolic Disorders, 26(7), 984–93. 
http://doi.org/10.1038/sj.ijo.0801968 
Targher, G., Bertolini, L., Poli, F., Rodella, S., Scala, L., Tessari, R., … Falezza, G. (2005). 
Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 
diabetic patients. Diabetes, 54(12), 3541–6. 
Targher, G., Bertolini, L., Rodella, S., Lippi, G., Franchini, M., Zoppini, G., … Day, C. P. 
(2008). NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral 
Fat in Men. Obesity, 16(6), 1394–1399. http://doi.org/10.1038/oby.2008.64 
Taylor, R. W., Keil, D., Gold, E. J., Williams, S. M., & Goulding, A. (1998). Body mass 
index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in 
19 
 
 
  
women: evaluation using receiver operating characteristic curves. American Journal of 
Clinical Nutrition, 67(1), 44–9. 
Wang, J., Thornton, J. C., Bari, S., Williamson, B., Gallagher, D., Heymsfield, S. B., … 
others. (2003). Comparisons of waist circumferences measured at 4 sites. The 
American Journal of Clinical Nutrition, 77(2), 379–384. 
World Health Organization. (2011). Waist circumference and waist-hip ratio: report of a 
WHO expert consultation, Geneva, 8-11 December 2008. Geneva: World Health 
Organization. 
Zheng, R. D., Chen, Z. R., Chen, J. N., Lu, Y. H., & Chen, J. (2012). Role of Body Mass 
Index, Waist-to-Height and Waist-to-Hip Ratio in Prediction of Nonalcoholic Fatty 
Liver Disease. Gastroenterology Research and Practice, 2012, 362147. 
http://doi.org/10.1155/2012/362147 
 
  
20 
 
 
  
TABLES: 
Table 1. Descriptive data of the studied sample. 
 NAFLD Patients (n=28) 
Variables Mean + SD *  Min. – Max. 
Age, yr (median, yr) 49.5 ± 12.8 (49)  25 – 68  
Sex, n female (% female)  9 (32.1)    
Anthropometry      
Weight, kg (CV, %) 87.6 ± 12.7 (0.07)  66.2 – 115.8  
Height, cm (CV, %) 167.2 ± 9.2 (0.03)  149.5 – 183.7  
BMI, kg/m2 (% obese) 29.1 ± 4.0 (32.1)  22.6 – 42.2  
WC 1, cm (CV, %) 100.7 ± 8.2# (0.45)  86.0 – 119.8  
WC 2, cm (CV, %) 104.8 ± 10.6# (0.49)  85.3 – 128.7  
WC 3, cm (CV, %) 103.7 ± 10.4# (0.47)  85.7 – 129.3  
WC 4, cm (CV, %) 106.3 ± 11.7# (0.73)  86.7 – 129.1  
Hip C, cm (CV, %) 107.6 ± 12.0 (0.38)  92.3 – 138.3  
WHR 1 (high WHR, %) 0.94 ± 0.07† (69.2)  0.75 – 1.03  
WHR 2 (high WHR, %) 0.98 ± 0.07† (76.9)  0.85 – 1.11  
WHR 3 (high WHR, %) 0.97 ± 0.07† (76.9)  0.82 – 1.09  
WHR 4 (high WHR, %) 0.99 ± 0.06† (84.6)  0.88 – 1.10  
Whole and Regional Body Fat      
BF, kg (%) 27.2 ± 9.3 (31.31 ± 8.20)  13.7 – 51.2 (18.84 – 46.28) 
Trunk BF, kg (%) 15.2 ± 5.2 (33.15 ± 7.65)  7.4 – 25.0 (20.87 – 48.01) 
Appendicular BF, kg (%) 10.8 ± 4.8 (30.42 ± 10.39)  5.2 – 25.7 (13.63 – 50.40) 
Abdominal BF, kg (%) 3.5 ± 1.2 (37.57 ± 6.59)  1.7 – 6.3 (26.09 – 49.40) 
Central Abdominal BF, kg (%) 2.9 ± 0.8 (35.82 ± 5.70)  1.6 – 5.0 (24.28 – 44.64) 
Body Fat distribution, ratios      
Trunk BF/ Appendicular BF ratio 1.477 ± 0.371   0.958 – 2.547  
Abdominal BF / Total BF ratio 0.130 ± 0.025   0.045 – 0.185  
Abdominal BF / Trunk BF ratio 1.231 ± 0.039   0.095 – 0.299  
CV – coefficient of variation; BMI – body mass index; WC1 – Waist circumference as measured by Lohman et al. {Lohman, 1988 #908} and Marfell-Jones {Marfell-
Jones, 2006 #270}; WC2 - Waist circumference as measured by the National Institute of Health (NIH) from the United States of America {NIH, 1994 #937}; WC3 - 
Waist circumference as measured by the World Health Organization (WHO) {WHO, 1987 #1015}; WC4 - Waist circumference as measured by Ross et al., Masson et 
al., Targher et al. and others {Ross, 2008 #969; Mason, 2009 #919; Targher, 2008 #412}; Hip C – Hip circumference; Thigh C – Thigh circumference; Calf C – Calf 
circumference; Arm C – Arm circumference; BF – body fat; FFM – fat free mass; * Results are presented as mean ± standard deviation, unless otherwise noted; Min. 
– lowest observed value; Máx. – highest observed value; HRR1 – heart rate recovery at 1 min.; HRR2 – heart rate recovery at 2 min.; BMI – body mass index; BF – 
body fat; FFM – fat free mass; # - different from all other WC mean values, p < 0.05 in paired samples t-test; † - different from all other WHR mean values, p < 0.05 
in paired samples t-test.     
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Table 2. Partial and semipartial correlations, controlled for age and sex. 
Variables WHR1   WHR2   WHR3   WHR4  
 † §  † §  † §  † § 
BF  - 0.17 - 0.12    0.13   0.09    0.09   0.06    0.10   0.07 
%BF - 0.02 - 0.02    0.15   0.08    0.13   0.07    0.12   0.06 
Trunk BF   0.05   0.04    0.35   0.27    0.31   0.25    0.31   0.25 
% Trunk BF   0.12   0.08    0.29   0.19    0.29   0.19    0.24   0.16 
Append BF - 0.42 - 0.28  - 0.16 - 0.11  - 0.21 - 0.13  - 0.17 - 0.11 
% Append BF - 0.18 - 0.08  - 0.06 - 0.03  - 0.08 - 0.04  - 0.05 - 0.02 
Abd BF   0.37   0.33    0.57**   0.51**    0.56**   0.50**  0.57**   0.51** 
% Abd BF   0.34   0.28    0.44   0.36    0.44   0.36    0.42*   0.35 
C Abd BF   0.40   0.39    0.60**   0.58**    0.58**   0.56**    0.57**   0.56** 
% C Abd BF   0.25   0.22    0.36   0.32    0.36   0.31    0.34   0.30 
Trunk BF/ Appendicular 
BF 
  0.45   0.37    0.56**   0.46    0.56**   0.46    0.51*   0.42 
Abd BF/ Total BF   0.52*   0.47    0.51*   0.46    0.54**   0.49    0.52*   0.47 
Abd BF/ Trunk BF   0.38   0.37    0.30   0.29    0.32   0.32    0.334   0.33 
WHR 1 – Waist-to-Hip ratio calculated using waist circumference measured at narrowest torso; WHR 2 - Waist-to-Hip ratio calculated using waist 
circumference measured at iliac crest; WHR 3 - Waist-to-Hip ratio calculated using waist circumference measured at midpoint between lowest rib and iliac 
crest; WHR 4 - Waist-to-Hip ratio calculated using waist circumference measured at the umbilicus; BF – body fat; Trunk BF – Trunk body fat; Append BF – 
appendicular body fat; Abd BF – Abdominal body fat; C Abd BF – Central abdominal body fat; † - partial correlations between studied WHR and dependent 
variables, controlled for age and sex; § - semipartial correlations between studied WHR and dependent variables, controlled for age and sex ; * - significant for 
p<0.05; ** - significant for p<0.01. 
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Table 3. Partial and semipartial correlations, controlled for age, sex and BMI. 
Variables WHR1   WHR2   WHR3   WHR4  
 † §  † §  † §  † § 
BF    0.06   0.03    0.19   0.13    0.18   0.10    0.15   0.08 
%BF   0.13   0.06    0.17   0.08    0.18   0.09    0.13   0.06 
Trunk BF   0.29   0.19    0.43   0.28    0.43   0.28    0.38   0.25 
% Trunk BF   0.27   0.17    0.33   0.20    0.34   0.21    0.26   0.16 
Append BF - 0.29 - 0.14  - 0.19 - 0.09  - 0.20 - 0.10  - 0.22 - 0.11 
% Append BF - 0.08 - 0.03  - 0.06 - 0.02  - 0.05 - 0.02  - 0.05 - 0.02 
Abd BF   0.47   0.41    0.59**   0.52**    0.59**   0.52**    0.58**   0.51** 
% Abd BF   0.39   0.32    0.45   0.37    0.44*   0.37    0.42   0.35* 
C Abd BF   0.48   0.46    0.61**   0.58**    0.60**   0.58**    0.58**   0.56** 
% C Abd BF   0.31   0.27    0.37   0.32    0.37   0.32    0.35   0.30 
Trunk BF/ Appendicular 
BF 
  0.45   0.38    0.56**   0.46    0.56**   0.46    0.51*   0.42* 
Abd BF/ Total BF   0.48   0.43    0.51*   0.46    0.53**   0.48    0.53*   0.47* 
Abd BF/ Trunk BF   0.32   0.30    0.30   0.28    0.32   0.30    0.34   0.32 
WHR 1 – Waist-to-Hip ratio calculated using waist circumference measured at narrowest torso; WHR 2 - Waist-to-Hip ratio calculated using waist 
circumference measured at iliac crest; WHR 3 - Waist-to-Hip ratio calculated using waist circumference measured at midpoint between lowest rib and iliac 
crest; WHR 4 - Waist-to-Hip ratio calculated using waist circumference measured at the umbilicus; BF – body fat; Trunk BF – Trunk body fat; Append BF – 
appendicular body fat; Abd BF – Abdominal body fat; C Abd BF – Central abdominal body fat; † - partial correlations between studied WHR and dependent 
variables, controlled for age and sex; § - semipartial correlations between studied WHR and dependent variables, controlled for age and sex ; * - significant for 
p<0.05; ** - significant for p<0.01. 
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FIGURE LEGENDS: 
Figure 1 Image of a DXA scan showing the central abdominal region of interest (R1) and the 
abdominal region of interest (R2). 
 
 
 
 
